RANKL and OPG Polymorphisms Are Associated with Aromatase Inhibitor-Related Musculoskeletal Adverse Events in Chinese Han Breast Cancer Patients

• Jingxuan Wang,

  Affiliation Department of Medical Oncology, The Third Hospital of Harbin Medical University, Harbin, China

  ⨯
• Kangping Lu,

  Affiliation Department of Medical Oncology, The Third Hospital of Harbin Medical University, Harbin, China

  ⨯
• Ying Song,

  Affiliation Department of Medical Oncology, The Third Hospital of Harbin Medical University, Harbin, China

  ⨯
• Shu Zhao,

  Affiliation Department of Medical Oncology, The Third Hospital of Harbin Medical University, Harbin, China

  ⨯
• Wenjie Ma,

  Affiliation Department of Medical Oncology, The Third Hospital of Harbin Medical University, Harbin, China

  ⨯
• Qijia Xuan,

  Affiliation Department of Medical Oncology, The Third Hospital of Harbin Medical University, Harbin, China

  ⨯
• Dabei Tang,

  Affiliation Department of Medical Oncology, The Third Hospital of Harbin Medical University, Harbin, China

  ⨯
• Hong Zhao,

  Affiliation Department of Medical Oncology, The Third Hospital of Harbin Medical University, Harbin, China

  ⨯
• Lei Liu,

  Affiliation Department of Medical Oncology, The Third Hospital of Harbin Medical University, Harbin, China

  ⨯
• Qingyuan Zhang

  * E-mail: zqywsci@163.com

  Affiliation Department of Medical Oncology, The Third Hospital of Harbin Medical University, Harbin, China

  ⨯